Compare Moderna, Inc. (MRNA) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Western Digital Corp — how do they compare? Moderna, Inc. trades at $224.94 (market cap $78.65B), while Western Digital Corp trades at $395.6 (market cap $147.23B). The key difference: Western Digital Corp is the larger of the two by market cap, and Western Digital Corp pays a 0.15% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Western Digital Corp for 37 Days on average.
| MRNA | WDC | |
|---|---|---|
Market Cap | $78.65B | $147.23B |
Volume | 37,373,437 | 9,341,468 |
Sector | Health | Technology |
52-Week High | $203.46 | $746.23 |
52-Week Low | $22.36 | $113.13 |
Typical Hold Time | 59 Days | 37 Days |
Enterprise Value | $74.80B | $146.70B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $225.00, up 14.52% in 24 hours, approaching its 52-week high. The stock shows strong technical momentum with bullish moving averages and support at $194. Fundamentally, while revenue has declined from pandemic peaks to $1.92B in 2025, the company continues to beat EPS expectations and maintains a robust pipeline in oncology and respiratory vaccines. Recent inclusion in the Nasdaq-100 index has generated positive momentum, though valuation metrics remain elevated with a P/S ratio of 35.08.
Outlook remains bifurcated - significant growth potential exists in the cancer vaccine pipeline and respiratory vaccine expansion, but current valuations appear stretched relative to financial performance. Key risks include execution challenges in new therapeutic areas, competitive pressure from Pfizer/BioNTech, and dependence on pipeline success beyond COVID-19 vaccines. Analyst consensus shows cautious optimism with a $115.70 price target despite recent downgrades.
Western Digital (WDC) trades at $397.28, down 1.96% amid recent sector volatility. The stock shows strong fundamentals with a 14.61 P/E ratio and impressive 71.97% net income margin, supported by three consecutive quarterly earnings beats. Technical indicators suggest bearish momentum with the price near pivot point support at $397. Recent news highlights competitive pressures from Toshiba's planned HDD production expansion, contributing to the stock's recent decline.
WDC presents a compelling value opportunity with strong profitability metrics and analyst consensus favoring bullish sentiment (72% buy ratings). However, investors face near-term risks from increased competition in AI storage markets and potential margin pressure. The $647.58 consensus price target suggests significant upside potential if the company maintains its competitive positioning and executes on growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
